Matinas BioPharma Holdings, Inc.

8-K Terminated a material agreement Jul 24, 2026 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws; Regulation FD disclosure; Other events Jul 13, 2026 8-K Delisting notice or listing-rule failure; Other events Jun 26, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Delisting notice or listing-rule failure Apr 3, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Director or officer change Jan 23, 2026 8-K Director or officer change Dec 12, 2025 8-K Director or officer change Nov 21, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Entered a material agreement; Unregistered sale of equity Aug 18, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Amended charter or bylaws Aug 6, 2025 8-K Director or officer change; Shareholder vote results Jun 23, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Modified rights of security holders; Director or officer change; Item 5.08; Other events May 2, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Unregistered sale of equity; Other events Apr 8, 2025 8-K Shareholder vote results Apr 4, 2025 8-K Director or officer change Mar 14, 2025 8-K Director or officer change; Other events Mar 11, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Other events Feb 13, 2025 8-K Director or officer change Feb 11, 2025 8-K Director or officer change; Other events Feb 7, 2025 8-K Director or officer change Jan 24, 2025 8-K Delisting notice or listing-rule failure Jan 10, 2025 8-K Director or officer change Nov 27, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Exit or disposal costs; Material impairment; Director or officer change; Regulation FD disclosure; Other events Oct 31, 2024 8-K Director or officer change Oct 24, 2024 8-K Modified rights of security holders; Amended charter or bylaws Sep 3, 2024 8-K Other events Aug 28, 2024 8-K Other events Aug 20, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Results of operations (earnings release) May 9, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Entered a material agreement; Regulation FD disclosure Apr 5, 2024 8-K Regulation FD disclosure Mar 28, 2024 8-K Results of operations (earnings release) Mar 27, 2024